CI

At a glance

ClinicalIndex Comparison Record
N/ACompleted· 67 enrolled
Drug / intervention
EUS-BD +1 moreprocedure
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT03054987
NCT03054987N/ACompleted

Randomized Trial Comparing Endoscopic Ultrasound-guided Biliary Drainage (EUS-BD) and Endoscopic Retrograde Cholangiopancreatography (ERCP) for Malignant Distal Biliary Obstruction

AdventHealth·interventional·Posted Feb 16, 2017·Updated Feb 15, 2019

In Brief

A clinical study evaluating EUS-BD and ERCP for Pancreatic Cancer and 2 related conditions. Completed, enrolled 67 participants across 1 site.

Detailed Summary

The purpose of this study is to compare the rates of adverse events between patients undergoing Endoscopic Ultrasound- guided biliary drainage and Endoscopic Retrograde Cholangiopancreatography for distal malignant biliary obstruction.

Study Details

Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
CountriesUnited States
Collaborators--

Timeline

N/ACompletedFinished
2017201820192020202120222023202420252026
First PostedFeb 16, 2017
Enrollment StartSep 1, 2016
Primary CompletionSep 1, 2018
Study CompletionOct 1, 2018
TodayJul 2, 2026
Enrollment to primary: 2 yearsPosted 9.4 years ago

Interventions

EUS-BDprocedure

EUS-BD is a minimally invasive technique where the common bile duct (choledochoduodenostomy) is punctured under EUS-guidance and after transmural dilation, a stent is deployed for biliary drainage.

ERCPprocedure

During the ERCP, a small catheter and guidewire is inserted into the bile duct and the stent can be deployed into the duct.